Activists argued that if all those who needed AIDS drugs could get them via this kind of funding, the very increase in the scale of production would drive drug costs down, which would in turn fuel further market growth, creating a virtuous cycle.
FORBES: AIDS Drugs ?C For Profit Or Not?